By Ed Miseta, Chief Editor, Clinical Leader
Follow Me On Twitter @EdClinical
There is no doubt that clinical trials, in general, need to improve. They take a long time, cost a lot, and are increasingly complex with multiple endpoints. Usually patient recruitment/retention is targeted as the biggest area in need of improvement. But what about the study protocol itself?
According to Victoria DiBiaso, global head of clinical operations strategy and collaboration at Sanofi, “When it comes to improving trials, you have to look at protocol optimization. For us, that is where it all begins. You can’t get good data without a successful trial, and you can’t have a successful trial without the right protocol.” She adds that communicating better with patients and sites is also an important part of the company’s current strategy to make its clinical trials more efficient.